Volume 272, Number 41,
Issue of October 10, 1997
pp. 26049-26055
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Peptide Mapping of the [125I]Iodoazidoketanserin
and
[125I]2-N-[(3
-Iodo-4
-azidophenyl)propionyl]tetrabenazine
Binding Sites for the Synaptic Vesicle Monoamine Transporter
(Received for publication, April 9, 1997, and in revised form, July 29, 1997)
Michael K.
Sievert
and
Arnold E.
Ruoho
From the Department of Pharmacology, University of Wisconsin
Medical School, Madison, Wisconsin 53706
The full-length cDNA for the rat recombinant
synaptic vesicle monoamine transporter (rVMAT2) containing a
COOH-terminal polyhistidine epitope was engineered into baculovirus DNA
for expression in Spodoptera frugiperda (Sf9) cells. Using
this recombinant baculovirus and cultured Sf9 cells, rVMAT2 has been
expressed to high levels and purified to >95% homogeneity using
immobilized Ni2+-affinity chromatography followed by
lectin (concanavalin A) chromatography. Purified transporter was
photolabeled using [125I]-7-azido-8-iodoketanserin
([125I]AZIK) and
[125I]2-N-[(3
-iodo-4
-azidophenyl)propionyl]tetrabenazine
([125I]TBZ-AIPP). Both [125I]AZIK and
[125I]TBZ-AIPP photoaffinity labeling of purified rVMAT2
were protectable by 10 µM tetrabenazine (TBZ), 10 µM 7-aminoketanserin, and 1 mM concentrations
of the transporter substrates dopamine, norepinephrine, and serotonin.
Radiolabeled peptides were generated using enzymatic and chemical
methods, purified using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, and NH2-terminal microsequenced.
Radiosequencing of [125I]AZIK-labeled rVMAT2 indicated
derivatization of Lys-20 in the NH2 terminus, just prior to
putative transmembrane domain 1 (TMD1). [125I]TBZ-AIPP
derivatized a segment of rVMAT2 between Gly-408 and Cys-431 in TMD10
and 11. These data implicate juxtaposition of TMD1 and 10/11.